PL1598350T3 - Pochodne pirolidyn i tiazolidyn, sposób ich wytwarzania i ich zastosowanie do leczenia hiperglikemii i cukrzycy typu II - Google Patents

Pochodne pirolidyn i tiazolidyn, sposób ich wytwarzania i ich zastosowanie do leczenia hiperglikemii i cukrzycy typu II

Info

Publication number
PL1598350T3
PL1598350T3 PL05291066T PL05291066T PL1598350T3 PL 1598350 T3 PL1598350 T3 PL 1598350T3 PL 05291066 T PL05291066 T PL 05291066T PL 05291066 T PL05291066 T PL 05291066T PL 1598350 T3 PL1598350 T3 PL 1598350T3
Authority
PL
Poland
Prior art keywords
diabetis
thiazolidines
hyperglycaemia
pyrrolidines
derivatives
Prior art date
Application number
PL05291066T
Other languages
English (en)
Inventor
Nanteuil Guillaume De
Alain Benoist
Murielle Combettes
Elizabeth Harley
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL1598350T3 publication Critical patent/PL1598350T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL05291066T 2004-05-19 2005-05-18 Pochodne pirolidyn i tiazolidyn, sposób ich wytwarzania i ich zastosowanie do leczenia hiperglikemii i cukrzycy typu II PL1598350T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0405454A FR2870538B1 (fr) 2004-05-19 2004-05-19 Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP05291066A EP1598350B1 (fr) 2004-05-19 2005-05-18 Dérivés de pyrrolidines et de thiazolidines, leur procédé de préparation et les utilisation pour le traitement de l'hyperglycémie et du diabète de type II

Publications (1)

Publication Number Publication Date
PL1598350T3 true PL1598350T3 (pl) 2007-10-31

Family

ID=34942306

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05291066T PL1598350T3 (pl) 2004-05-19 2005-05-18 Pochodne pirolidyn i tiazolidyn, sposób ich wytwarzania i ich zastosowanie do leczenia hiperglikemii i cukrzycy typu II

Country Status (29)

Country Link
US (1) US7439263B2 (pl)
EP (1) EP1598350B1 (pl)
JP (1) JP4335171B2 (pl)
KR (1) KR100747967B1 (pl)
CN (1) CN100381438C (pl)
AR (1) AR049278A1 (pl)
AT (1) ATE366731T1 (pl)
AU (1) AU2005202180B2 (pl)
BR (1) BRPI0501769A (pl)
CA (1) CA2506491C (pl)
CY (1) CY1106878T1 (pl)
DE (1) DE602005001576T2 (pl)
DK (1) DK1598350T3 (pl)
EA (1) EA009292B1 (pl)
ES (1) ES2290864T3 (pl)
FR (1) FR2870538B1 (pl)
GE (1) GEP20074103B (pl)
HK (1) HK1086259A1 (pl)
HR (1) HRP20070376T3 (pl)
MX (1) MXPA05005256A (pl)
MY (1) MY139481A (pl)
NO (1) NO330294B1 (pl)
NZ (1) NZ540108A (pl)
PL (1) PL1598350T3 (pl)
PT (1) PT1598350E (pl)
RS (1) RS50526B (pl)
SG (1) SG117551A1 (pl)
SI (1) SI1598350T1 (pl)
ZA (1) ZA200504050B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020413A1 (de) 2007-08-02 2009-02-04 Bayer CropScience AG Oxaspirocyclische-spiro-substituierte Tetram- und Tetronsäure-Derivate
GB2465132B (en) * 2007-09-21 2012-06-06 Lupin Ltd Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
RU2487866C2 (ru) * 2008-01-23 2013-07-20 Цзянсу Хэнсох Фармасьютикал Ко., Лтд. Производные дициклоазаалкана, способы их получения и их применение в медицине
WO2010146597A1 (en) 2009-06-18 2010-12-23 Lupin Limited 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
CN103508931B (zh) 2012-06-25 2016-03-02 广东东阳光药业有限公司 六氢并环戊二烯衍生物、其制备方法及其在医药上的应用
KR102449196B1 (ko) 2016-01-15 2022-09-29 삼성전자주식회사 비휘발성 메모리 장치 및 비휘발성 메모리 장치의 프로그램 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618957B2 (ja) * 1988-01-26 1994-03-16 日本合成化学工業株式会社 成形物の製造方法
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4222459C2 (de) * 1992-07-08 1995-09-14 Sigma Tau Ind Farmaceuti 3,9-disubstituierte-Spiro[5.5]undecane, ein Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten
US5981567A (en) * 1993-07-02 1999-11-09 Bayer Aktiengesellschaft Substituted spiroheterocyclic 1h-3-aryl-pyrrolidine-2,4-dione derivatives and their use as pesticides
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6110949A (en) * 1999-06-24 2000-08-29 Novartis Ag N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
TW583185B (en) * 2000-06-13 2004-04-11 Novartis Ag N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
ES2311534T3 (es) * 2000-08-10 2009-02-16 Mitsubishi Tanabe Pharma Corporation Derivados de prolina y su uso como farmacos.
ES2271071T3 (es) * 2000-09-25 2007-04-16 Toray Industries, Inc. Compuestos espiro e inhibidores de moleculas de adherencia que contienen dichos compuestos como ingrediente activo.
FR2824825B1 (fr) * 2001-05-15 2005-05-06 Servier Lab Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2003057144A2 (en) * 2001-12-26 2003-07-17 Guilford Pharmaceuticals Change inhibitors of dipeptidyl peptidase iv
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
CN1633420A (zh) * 2002-04-08 2005-06-29 托伦脱药品有限公司 噻唑烷－4－腈和类似物以及它们作为二肽基－肽酶抑制剂的用途
TW200404796A (en) * 2002-08-19 2004-04-01 Ono Pharmaceutical Co Nitrogen-containing compound
US7262207B2 (en) * 2002-09-19 2007-08-28 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
AU2003290577B2 (en) * 2002-11-07 2008-12-11 Merck Sharp & Dohme Corp. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Also Published As

Publication number Publication date
RS50526B (sr) 2010-05-07
NO20052414L (no) 2005-11-21
ATE366731T1 (de) 2007-08-15
CA2506491A1 (fr) 2005-11-19
EA009292B1 (ru) 2007-12-28
JP4335171B2 (ja) 2009-09-30
JP2005350456A (ja) 2005-12-22
US7439263B2 (en) 2008-10-21
US20050261501A1 (en) 2005-11-24
GEP20074103B (en) 2007-05-10
EP1598350B1 (fr) 2007-07-11
NO20052414D0 (no) 2005-05-19
ZA200504050B (en) 2006-07-26
DE602005001576T2 (de) 2008-04-17
PT1598350E (pt) 2007-10-04
SI1598350T1 (sl) 2007-10-31
DE602005001576D1 (de) 2007-08-23
ES2290864T3 (es) 2008-02-16
MXPA05005256A (es) 2005-11-24
EA200500683A1 (ru) 2005-12-29
DK1598350T3 (da) 2007-11-12
CY1106878T1 (el) 2012-09-26
NO330294B1 (no) 2011-03-21
SG117551A1 (en) 2005-12-29
FR2870538A1 (fr) 2005-11-25
EP1598350A1 (fr) 2005-11-23
HK1086259A1 (en) 2006-09-15
AR049278A1 (es) 2006-07-12
AU2005202180A1 (en) 2005-12-08
CN100381438C (zh) 2008-04-16
CN1721417A (zh) 2006-01-18
AU2005202180B2 (en) 2010-10-28
BRPI0501769A (pt) 2006-01-10
CA2506491C (fr) 2009-09-01
FR2870538B1 (fr) 2006-07-14
KR100747967B1 (ko) 2007-08-08
HRP20070376T3 (en) 2007-12-31
KR20060048007A (ko) 2006-05-18
MY139481A (en) 2009-10-30
NZ540108A (en) 2006-04-28

Similar Documents

Publication Publication Date Title
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
ZA200700705B (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
EP1731506A4 (en) 5-HYDROXYINDOL-3-CARBOXYLATE DERIVATIVES AND THEIR USE
EP1826209A4 (en) NITROMETHYLENE DERIVATIVES AND THEIR USE
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
ZA200606678B (en) 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
ZA200803670B (en) Pyrazole derivatives and their medical use
IL177047A0 (en) Oxazole derivatives, preparation and therapeutic use thereof
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
IL187392A0 (en) Thiazole derivatives, their preparation and use
TWI349551B (en) Thiophenepyrimidinone derivatives and their use in therapy
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
IL178765A0 (en) 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
PL377180A1 (pl) Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz
SI1598350T1 (sl) Derivati pirolidinov in triazolidinov, postopek za njihovo pripravo in njihova uporaba za zdravljenje hiperglikemije in diabetesa tipa ii
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
ZA200903865B (en) Pyrrole derivatives, preparation and use of the same in therapy
IL180867A0 (en) Pyrrole derivatives, their preparation and their therapeutic use
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
HK1107340A1 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof